Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Net Income (Common) Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Net Income (Common)
â‚ą16.4B
CAGR 3-Years
61%
CAGR 5-Years
22%
CAGR 10-Years
30%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
â‚ą55.7B
CAGR 3-Years
47%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income (Common)
â‚ą44.8B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
â‚ą110.5B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
â‚ą18B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income (Common)
â‚ą19.1B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Net Income (Common)?
Net Income (Common)
16.4B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Net Income (Common) amounts to 16.4B INR.

What is Natco Pharma Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
30%

Over the last year, the Net Income (Common) growth was 101%. The average annual Net Income (Common) growth rates for Natco Pharma Ltd have been 61% over the past three years , 22% over the past five years , and 30% over the past ten years .

Back to Top